An Assessment of Statin Safety by Nephrologists

Bert L Kasiske, Christoph Wanner, W. Charles O'Neill

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Recently, concerns regarding potential adverse effects of the statins on the kidney have been raised. The Kidney Expert Panel of the National Lipid Association's (NLA) Safety Task Force, made up of 3 nephrologists, was convened to review all of the currently available evidence pertinent to determining whether statins cause kidney injury, independent of the known, rare mechanisms of rhabdomyolysis and allergic, drug-induced, interstitial nephritis. The Panel reviewed published and unpublished evidence and found none that suggested that statins, when used in doses currently approved by the US Food and Drug Administration (FDA), cause kidney injury.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
Volume97
Issue number8 SUPPL. 1
DOIs
StatePublished - Apr 17 2006

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Kidney
Safety
Interstitial Nephritis
Rhabdomyolysis
Wounds and Injuries
Advisory Committees
United States Food and Drug Administration
Lipids
Nephrologists
Pharmaceutical Preparations

Cite this

An Assessment of Statin Safety by Nephrologists. / Kasiske, Bert L; Wanner, Christoph; O'Neill, W. Charles.

In: American Journal of Cardiology, Vol. 97, No. 8 SUPPL. 1, 17.04.2006.

Research output: Contribution to journalArticle

Kasiske, Bert L ; Wanner, Christoph ; O'Neill, W. Charles. / An Assessment of Statin Safety by Nephrologists. In: American Journal of Cardiology. 2006 ; Vol. 97, No. 8 SUPPL. 1.
@article{729f24d296574924b94718ac204e1b77,
title = "An Assessment of Statin Safety by Nephrologists",
abstract = "Recently, concerns regarding potential adverse effects of the statins on the kidney have been raised. The Kidney Expert Panel of the National Lipid Association's (NLA) Safety Task Force, made up of 3 nephrologists, was convened to review all of the currently available evidence pertinent to determining whether statins cause kidney injury, independent of the known, rare mechanisms of rhabdomyolysis and allergic, drug-induced, interstitial nephritis. The Panel reviewed published and unpublished evidence and found none that suggested that statins, when used in doses currently approved by the US Food and Drug Administration (FDA), cause kidney injury.",
author = "Kasiske, {Bert L} and Christoph Wanner and O'Neill, {W. Charles}",
year = "2006",
month = "4",
day = "17",
doi = "10.1016/j.amjcard.2005.12.015",
language = "English (US)",
volume = "97",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8 SUPPL. 1",

}

TY - JOUR

T1 - An Assessment of Statin Safety by Nephrologists

AU - Kasiske, Bert L

AU - Wanner, Christoph

AU - O'Neill, W. Charles

PY - 2006/4/17

Y1 - 2006/4/17

N2 - Recently, concerns regarding potential adverse effects of the statins on the kidney have been raised. The Kidney Expert Panel of the National Lipid Association's (NLA) Safety Task Force, made up of 3 nephrologists, was convened to review all of the currently available evidence pertinent to determining whether statins cause kidney injury, independent of the known, rare mechanisms of rhabdomyolysis and allergic, drug-induced, interstitial nephritis. The Panel reviewed published and unpublished evidence and found none that suggested that statins, when used in doses currently approved by the US Food and Drug Administration (FDA), cause kidney injury.

AB - Recently, concerns regarding potential adverse effects of the statins on the kidney have been raised. The Kidney Expert Panel of the National Lipid Association's (NLA) Safety Task Force, made up of 3 nephrologists, was convened to review all of the currently available evidence pertinent to determining whether statins cause kidney injury, independent of the known, rare mechanisms of rhabdomyolysis and allergic, drug-induced, interstitial nephritis. The Panel reviewed published and unpublished evidence and found none that suggested that statins, when used in doses currently approved by the US Food and Drug Administration (FDA), cause kidney injury.

UR - http://www.scopus.com/inward/record.url?scp=33645887517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645887517&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.12.015

DO - 10.1016/j.amjcard.2005.12.015

M3 - Article

C2 - 16581334

AN - SCOPUS:33645887517

VL - 97

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8 SUPPL. 1

ER -